#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15496	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2439	762.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1689	1689	C	941	C	941	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	0	.	n	.	0	T695C	SNP	695	695	T	1367	1367	C	1039	C,T,G,A	1033,3,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	2009	2009	A	1051	A,G,C	1048,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2643	2643	C	926	C,T	923,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2717	2717	A	926	A,C	925,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3269	3269	C	982	C,G,A	978,2,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26268	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4160	788.3	0	HET	.	.	.	C76CGGGGG,CGGGG	.	76	76	C	748	748	C	940	CGGGGG,CGGGG	455,430	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2106	folP	855	855	100.0	folP.l15.c4.ctg.1	2115	124.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1249	1251	AGC	206;210;208	A;G;C	206;210;208	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5346	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	4101	162.8	1	SNP	p	S91F	1	.	.	271	273	TTC	952	954	TTC	200;201;201	T;T;C,G	200;201;200,1	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5346	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	4101	162.8	1	SNP	p	D95N	0	.	.	283	285	GAC	964	966	GAC	199;198;197	G,A;A;C	198,1;198;197	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5346	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	4101	162.8	1	SNP	p	D95G	0	.	.	283	285	GAC	964	966	GAC	199;198;197	G,A;A;C	198,1;198;197	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2000	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1805	138.1	1	SNP	p	G45D	1	.	.	133	135	GAC	697	699	GAC	225;225;226	G;A,C;C,A	225;224,1;225,1	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1114	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1569	88.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	5106	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3553	179.5	1	SNP	p	D86N	0	.	.	256	258	GAC	886	888	GAC	209;210;208	G;A;C	209;210;208	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	5106	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3553	179.5	1	SNP	p	S87R	0	.	.	259	261	AGT	889	891	AGT	203;200;200	A,C;G;T,C	202,1;200;199,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	5106	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3553	179.5	1	SNP	p	S87W	0	.	.	259	261	AGT	889	891	AGT	203;200;200	A,C;G;T,C	202,1;200;199,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	5106	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3553	179.5	1	SNP	p	S87I	0	.	.	259	261	AGT	889	891	AGT	203;200;200	A,C;G;T,C	202,1;200;199,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	5106	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3553	179.5	1	SNP	p	S88P	0	.	.	262	264	TCC	892	894	TCC	203;204;208	T,G;C;C,G	202,1;204;207,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4298	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3097	173.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1768	1770	GGC	236;236;236	G;G,C;C	236;235,1;236	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	254;253;254	G;C;A	254;253;254	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	252;248;248	A,C;T,A;C	251,1;247,1;248	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	261;267;266	G,T;T,C;G	260,1;266,1;266	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	261;267;266	G,T;T,C;G	260,1;266,1;266	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	232;230;230	A,G;C;C,T	230,2;230;229,1	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	223;224;223	G,T;C,T;G	222,1;223,1;223	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	223;224;223	G,T;C,T;G	222,1;223,1;223	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2161	2163	AGC	210;210;210	A;G,T;C,T	210;209,1;209,1	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	209;211;213	G;G,T;C	209;210,1;213	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	4052	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2855	177.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2188	2190	CCG	218;219;212	C,G;C;G,C	217,1;219;209,3	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5362	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3601	185.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1950	1952	CCG	211;211;209	C,G;C;G	210,1;211;209	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2430	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2167	139.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	557	559	GGC	170;170;166	G,C;G,C;C	169,1;168,1;166	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2430	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2167	139.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	739	739	C	161	C	161	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	100	94.0	porB1a.l15.c17.ctg.1	181	47.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	54;54;51	A;C;G	54;54;51	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	100	94.0	porB1a.l15.c17.ctg.1	181	47.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	14;10;9	C;A;A	14;10;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	442	444	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	445	447	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	469	471	GCA	10;10;10	G;C;A	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	492	494	GTA	10;10;10	G;T;A	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	498	500	AAC	9;9;9	A;A;C	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	.	MULTIPLE	709	711	AAC	502	506	TGGCG	9;9;9;9;9	T;G;G;C;G	9;9;9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	D238A	NONSYN	712	714	GAT	508	510	GCT	9;9;9	G;C;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	A251V	NONSYN	751	753	GCG	547	549	GTA	24;24;22	G;T;A	24;24;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	S271T	NONSYN	811	813	TCG	607	609	ACT	78;78;78	A,T;C;T	77,1;78;78	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	613	615	GAT	78;78;78	G,C;A;T	77,1;78;78	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	D276N	NONSYN	826	828	GAT	622	624	AAC	78;78;78	A,G;A;C	77,1;78;78	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	312	porB1a	984	292	90.2	porB1a.l15.c17.ctg.2	709	29.3	0	.	p	.	0	N277H	NONSYN	829	831	AAC	625	627	CAC	78;78;78	C,T;A;C	77,1;78;78	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	S36Y	NONSYN	106	108	TCT	764	766	TAT	222;225;223	T;A;T,A	222;225;222,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	K120D	NONSYN	358	360	AAG	1016	1018	GAC	220;219;217	G;A;C	220;219;217	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	K208del	DEL	622	622	A	1279	1279	A	222	A	221	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	G211S	NONSYN	631	633	GGC	1286	1288	AGC	211;207;207	A;G;C	211;207;207	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1301	1303	ATC	207;207;209	A,G;T;C	206,1;207;209	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2854	porB1b	1041	1041	99.04	porB1b.l6.c17.ctg.1	2151	165.5	0	.	p	.	0	I333T	NONSYN	997	999	ATC	1652	1654	ACC	262;260;260	A,C;C,T;C	261,1;259,1;260	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9636	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5330	225.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1506	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1558	120.6	1	SNP	p	V57M	1	.	.	169	171	ATG	758	760	ATG	277;275;275	A,C;T,G;G	276,1;274,1;275	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
